Platelet-rich plasma injection with arthroscopic acromioplasty for chronic rotator cuff tendinopathy

American Journal of Sports Medicine

Volumn 43, Issue 12, 2015, Pages 2891-2897

  Carr, Andrew J ^a   Murphy, Richard ^a   Dakin, Stephanie G ^a   Rombach, I N E S ^a   Wheway, K I M ^a   Watkins, Bridget ^a   Franklin, Sarah L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acromioplasty; platelet rich plasma; rotator cuff; tendinopathy

Indexed keywords

ADULT; AGED; ARTHROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; ROTATOR CUFF; SHOULDER PAIN; SUBCUTANEOUS DRUG ADMINISTRATION; TENDINOPATHY; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; WOUND HEALING;

ADULT; AGED; ARTHROSCOPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; PLATELET-RICH PLASMA; ROTATOR CUFF; SHOULDER PAIN; TENDINOPATHY; TREATMENT OUTCOME; WOUND HEALING;

EID: 84948964381     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546515608485     Document Type: Article

References (40)

1. Alsousou J, Thompson M, Hulley P, Noble A, Willett K., The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009; 91 (8): 987-996.
2. Anitua E., Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants. 1999; 14 (4): 529-535.
3. Anitua E, Andia I, Sanchez M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res. 2005; 23 (2): 281-286.
4. Baksh N, Hannon CP, Murawski CD, Smyth NA, Kennedy JG., Platelet-rich plasma in tendon models: a systematic review of basic science literature. Arthroscopy. 2013; 29 (3): 596-607.
5. Barber FA, Hrnack SA, Snyder SJ, Hapa O., Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation. Arthroscopy. 2011; 27 (8): 1029-1035.
6. Beck J, Evans D, Tonino PM, Yong S, Callaci JJ., The biomechanical and histologic effects of platelet-rich plasma on rat rotator cuff repairs. Am J Sports Med. 2012; 40 (9): 2037-2044.
7. Carr A, Cooper C, Murphy R, et al. PARot-assessing platelet-rich plasma plus arthroscopic subacromial decompression in the treatment of rotator cuff tendinopathy: study protocol for a randomized controlled trial. Trials. 2013; 14 (1): 167.
8. Castricini R, Longo UG, De Benedetto M, et al. Platelet-rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med. 2011; 39 (2): 258-265.
9. Chaudhury S, Gwilym SE, Moser J, Carr AJ,. Surgical options for patients with shoulder pain. Nat Rev Rheumatol. 2010; 6 (4): 217-226.
10. Cook JL, Feller JA, Bonar SF, Khan KM,. Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons. J Orthop Res. 2004; 22 (2): 334-338.
11. Dawson J, Fitzpatrick R, Carr A,. Questionnaire on the perceptions of patients about shoulder surgery. J Bone Joint Surg Br. 1996; 78 (4): 593-600.
12. de Jonge S, de Vos RJ, Weir A, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011; 39 (8): 1623-1629.
13. de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010; 303 (2): 144-149.
14. de Vos RJ, Windt J, Weir A,. Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review. Br J Sports Med. 2014; 48 (12): 952-956.
15. Fergusson D, Aaron SD, Guyatt G, Hebert P,. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ. 2002; 325 (7365): 652-654.
16. Franklin SL, Dean BJ, Wheway K, Watkins B, Javaid MK, Carr AJ,. Up-regulation of glutamate in painful human supraspinatus tendon tears. Am J Sports Med. 2014; 42 (8): 1955-1962.
17. Gumina S, Campagna V, Ferrazza G, et al. Use of platelet-leukocyte membrane in arthroscopic repair of large rotator cuff tears: a prospective randomized study. J Bone Joint Surg Am. 2012; 94 (15): 1345-1352.
18. Gupta G,. Clinical and radiographic evaluation of intra-bony defects in localized aggressive periodontitis patients with platelet rich plasma/hydroxyapatite graft: a comparative controlled clinical trial. Contemp Clin Dent. 2014; 5 (4): 445-451.
19. Hee HT, Majd ME, Holt RT, Myers L,. Do autologous growth factors enhance transforaminal lumbar interbody fusion? Eur Spine J. 2003; 12 (4): 400-407.
20. Hermans J, Luime JJ, Meuffels DE, Reijman M, Simel DL, Bierma-Zeinstra SM,. Does this patient with shoulder pain have rotator cuff disease? The Rational Clinical Examination systematic review. JAMA. 2013; 310 (8): 837-847.
21. Isaac C, Gharaibeh B, Witt M, Wright VJ, Huard J,. Biologic approaches to enhance rotator cuff healing after injury. J Shoulder Elbow Surg. 2012; 21 (2): 181-190.
22. Jo CH, Shin JS, Lee YG, et al. Platelet-rich plasma for arthroscopic repair of large to massive rotator cuff tears: a randomized, single-blind, parallel-group trial. Am J Sports Med. 2013; 41 (10): 2240-2248.
23. Judge A, Murphy RJ, Maxwell R, Arden NK, Carr AJ,. Temporal trends and geographical variation in the use of subacromial decompression and rotator cuff repair of the shoulder in England. Bone Joint J. 2014; 96 (1): 70-74.
24. Kesikburun S, Tan AK, Yilmaz B, Yasar E, Yazicioglu K,. Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up. Am J Sports Med. 2013; 41 (11): 2609-2616.
25. Ketola S, Lehtinen J, Arnala I, et al. Does arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome? A two-year randomised controlled trial. J Bone Joint Surg Br. 2009; 91 (10): 1326-1334.
26. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN,. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001; 2 (7): 612-619.
27. Lucas T, Waisman A, Ranjan R, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010; 184 (7): 3964-3977.
28. Lundgreen K, Lian O, Scott A, Engebretsen L,. Increased levels of apoptosis and p53 in partial-thickness supraspinatus tendon tears. Knee Surg Sports Traumatol Arthrosc. 2013; 21 (7): 1636-1641.
29. Lundgreen K, Lian OB, Engebretsen L, Scott A,. Tenocyte apoptosis in the torn rotator cuff: a primary or secondary pathological event? Br J Sports Med. 2011; 45 (13): 1035-1039.
30. Moraes V, Kenza M, Tamaoki M, Faloppa F, Belloti J,. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014; 4: CD010071.
31. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC,. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2013; 12: CD010071.
32. Murphy RJ, Carr AJ,. Shoulder pain. BMJ Clin Evid. 2010; 2010.
33. Murphy RJ, Floyd Dean BJ, Wheway K, Watkins B, Morrey ME, Carr AJ,. A novel minimally invasive ultrasound-guided technique to biopsy supraspinatus tendon. Oper Tech Orthop. 2013; 23 (2): 56-62.
34. Pietrzak WS, Eppley BL,. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005; 16 (6): 1043-1054.
35. Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P,. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg. 2011; 20 (4): 518-528.
36. Rha DW, Park GY, Kim YK, Kim MT, Lee SC,. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013; 27 (2): 113-122.
37. Scarpone M, Rabago D, Snell E, et al. Effectiveness of platelet-rich plasma injection for rotator cuff tendinopathy: a prospective open-label study. Glob Adv Health Med. 2013; 2 (2): 26-31.
38. Serhan CN, Savill J,. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005; 6 (12): 1191-1197.
39. Weibrich G, Kleis WK, Hafner G, Hitzler WE,. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002; 30 (2): 97-102.
40. Wynn TA,. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004; 4 (8): 583-594.